-
1
المؤلفون: Yuhong Zhou, Ying Guo, Kay Delasalle, Vivian Green, Jorge E. Romaguera, Maria Badillo, Joseph S. Chiang, Raymond Alexanian, M. Kay Garcia, Liang Zhang, Richard T. Lee, Michael Wang, Jatin P. Shah, Sheeba K. Thomas, Yiming Chen, Qi Wei, Bing You, Donna M. Weber, Lorenzo Cohen, Robert Z. Orlowski
المصدر: Journal of Hematology & Oncology
مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Cancer Research, Time Factors, Peripheral neuropathy, Electroacupuncture, medicine.medical_treatment, Myeloma, Bortezomib, immune system diseases, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Chemotherapy, Integrative medicine, Molecular Biology, Multiple myeloma, Aged, Pain Measurement, Hematology, business.industry, Research, Cancer, Peripheral Nervous System Diseases, Acupuncture, Middle Aged, medicine.disease, Boronic Acids, 3. Good health, Thalidomide, Treatment Outcome, Pyrazines, Immunology, Feasibility Studies, Female, business, Multiple Myeloma, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8692a25089130b98625a8fd4159819a3Test
https://pubmed.ncbi.nlm.nih.gov/24886772Test -
2
المؤلفون: Antonio Palumbo, Philippe Moreau, Michele Cavo, Paul G. Richardson, Jean Luc Harousseau, Robert Z. Orlowski, Jesuś F. San Miguel
المساهمون: Hôtel-Dieu Hospital (France)
المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instnameمصطلحات موضوعية: Oncology, medicine.medical_specialty, Time Factors, Immunology, Antineoplastic Agents, Review Article, Pharmacology, Cysteine Proteinase Inhibitors, Medical Oncology, Biochemistry, Bortezomib, chemistry.chemical_compound, Autologous stem-cell transplantation, Refractory, immune system diseases, Internal medicine, hemic and lymphatic diseases, medicine, Animals, Humans, Multiple myeloma, Therapeutic strategy, business.industry, Cell Biology, Hematology, medicine.disease, Carfilzomib, Boronic Acids, chemistry, Proteasome, Pyrazines, Proteasome inhibitor, business, Multiple Myeloma, Proteasome Inhibitors, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb2b7bf471f749f8d6a91fb7975ae553Test
http://hdl.handle.net/10261/134214Test -
3
المؤلفون: Nadine Cohen, Jean Luc Harousseau, Pieter Sonneveld, Conway C. Huang, Robert Z. Orlowski, Joan Bladé, Reyna Favis, Gabriele Buda, Sen H. Zhuang, Deborah Ricci
المصدر: Annals of Hematology
مصطلحات موضوعية: Oncology, Time Factors, Drug resistance, Kaplan-Meier Estimate, Pharmacology, Polyethylene Glycols, Bortezomib, Recurrence, Multiple myeloma, hemic and lymphatic diseases, Medicine, Prospective cohort study, Aged, 80 and over, education.field_of_study, Clinical Trials as Topic, Hematology, General Medicine, Middle Aged, Boronic Acids, Pyrazines, Disease Progression, Original Article, MRP1, medicine.drug, Adult, medicine.medical_specialty, ATP Binding Cassette Transporter, Subfamily B, Population, SNP, Antineoplastic Agents, MDR1, Polymorphism, Single Nucleotide, Disease-Free Survival, Internal medicine, Pegylated liposomal doxorubicin, Genetic model, Humans, Doxorubicin, ATP Binding Cassette Transporter, Subfamily B, Member 1, education, neoplasms, Aged, Retrospective Studies, business.industry, medicine.disease, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f11d7310303ee78d3f083aa964a0493Test
https://pubmed.ncbi.nlm.nih.gov/20532504Test -
4
المؤلفون: E. Claire Dees, Reynaldo Garcia, Suzanne E. Biehn, Robert Z. Orlowski, Peter M. Voorhees, Dominic T. Moore, Mary Jo Lehman
المصدر: Annals of hematology. 86(3)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Time Factors, Kaplan-Meier Estimate, Pharmacology, Polyethylene Glycols, Bortezomib, immune system diseases, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Doxorubicin, Multiple myeloma, Aged, Hematology, business.industry, General Medicine, Middle Aged, medicine.disease, Boronic Acids, Phase i study, Regimen, Prior Therapy, Treatment Outcome, Pyrazines, Proteasome inhibitor, Drug Therapy, Combination, business, Multiple Myeloma, medicine.drug, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed6301c4a7368e83c9b35cf44b3feffTest
https://pubmed.ncbi.nlm.nih.gov/17146676Test